The Effect of Addiction Management Model on Digital Addiction and Psychological Resilience in Sec… (NCT06468839) | Clinical Trial Compass
CompletedNot Applicable
The Effect of Addiction Management Model on Digital Addiction and Psychological Resilience in Secondary School Students
Turkey (Türkiye)80 participantsStarted 2024-03-18
Plain-language summary
This study aims to examine the effect of an addiction management model applied to sixth-grade middle school students at high risk of digital addiction on digital addiction and psychological resilience. In this study, sixth-grade students' digital addiction risks were first assessed through a questionnaire. A parallel group, randomized controlled experimental design was used in the research. According to the power analysis results, it was determined that the sample size should be at least 72 people. Due to possible losses, 10% more participants were accepted into the study, and 80 students who met the inclusion criteria were assigned to the intervention n=40 and control n=40 groups. The study will utilize personal information forms, the Digital Addiction Scale for Children, and the Child and Adolescent Psychological Resilience Scale. The data collection process will be conducted in three stages: pre-test, post-test, and 1-month follow-up test.
Who can participate
Age range
11 Years – 12 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Volunteering to participate in the research Being a 6th-grade student in middle school. Being 11 or 12 age. Being able to read, understand, and speak Turkish fluently. Having no auditory or cognitive impairments that would hinder participation. Scoring 65 or above on the Digital Addiction Scale for Children (DASC).- Having voluntary consent provided by both the student and their legal guardian (parental consent)
Exclusion Criteria:
Scoring below 65 on the Digital Addiction Scale for Children (DASC) during the initial screening
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Digital Addiction Scale for Children
Timeframe: before the intervention, six weeks after the start of intervention, four weeks after implementation of the intervention